Australia markets closed

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.70+0.83 (+8.41%)
At close: 04:00PM EST
10.32 -0.38 (-3.55%)
After hours: 08:00PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
Total revenue
0
0
0
Operating expenses
Research development
15,512
13,227
9,545
Selling general and administrative
7,297
6,007
3,349
Total operating expenses
22,809
19,234
12,894
Operating income or loss
-22,809
-19,234
-12,894
Income before tax
-22,334
-19,085
-12,890
Income from continuing operations
-22,334
-19,085
-12,890
Net income
-22,334
-19,085
-12,890
Net income available to common shareholders
-22,334
-19,085
-12,890
Basic EPS
-1.50
-1.51
-1.09
Diluted EPS
-1.50
-1.51
-1.09
Basic average shares
15,172
12,658
12,718
Diluted average shares
15,172
12,658
12,718